Physician profile
Keith V Regets
NPI 1164725677
$119,423.50
in general payments reported to CMS, 2019-2025
20 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,119 · 2022: $37K · 2023: $36K · 2024: $26K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $37K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Consulting Fee: $9,417 · Travel and Lodging: $7,803 · Food and Beverage: $6,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $37,125.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,718.21 |
| Consulting Fee | $9,417.22 |
| Travel and Lodging | $7,802.97 |
| Food and Beverage | $6,633.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $76,892.25 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Boston Scientific Corporation | $27,612.62 | 2021-2025 | Ams 700 Cxr Rte Kit, Ams 700, Tactra |
| Endo USA, INC. | $5,289.41 | 2024-2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $3,906.74 | 2021-2024 | Xiaflex |
| Verity Pharmaceuticals INC. | $3,846.58 | 2025 | Tlando |
| Halozyme INC | $706.08 | 2023 | |
| Urogen Pharma, INC. | $185.37 | 2023-2025 | Jelmyto |
| Procept Biorobotics Corporation | $157.32 | 2025 | |
| Axonics, INC. | $155.77 | 2024 | Axonics |
| Teleflex LLC | $143.11 | 2023-2025 | Urolift, Barrigel |
| Innovation Technologies INC | $141.24 | 2023 | Irrisept |
| Gilead Sciences, INC. | $110.63 | 2022 | |
| Abbvie INC. | $91.23 | 2022 | |
| Baxter Healthcare | $55.97 | 2024 | Tisseel |
| Progenics Pharmaceuticals, INC. | $35.03 | 2021-2023 | Pylarify |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $24.16 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Sumitomo Pharma America, INC. | $23.66 | 2025 | Gemtesa |
| Abc Home Medical Supply, INC. | $18.38 | 2025 | |
| Novo Nordisk INC | $16.62 | 2024 | |
| Clarus Therapeutics INC. | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Regets listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.